Baxter Intl receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Baxter International (BAX)
Assess today's live Baxter International (BAX) share price, performance and insights using our live NYSE: BAX stock exchange data.
Analyse the historical data and Baxter International share price performance charts on this page. Our technical summary section provides analysis on Baxter share price buy/sell indicators using real-time data (or discuss the Baxter (BAX) stock price today with other investors in the Baxter NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE BAX share price (ISIN: US0718131099) to enhance your trading decisions with our free investment tools and resources.
What Is the Baxter International Share Price Today?
The Baxter share price today is 19.76.
What Is the Stock Symbol for Baxter International
The stock symbol (or 'ticker') for Baxter International Inc is "BAX."
What Stock Exchange Does Baxter International Trade On?
Baxter International Inc is listed and trades on the NYSE stock exchange.
Is Baxter International a Good Stock to Buy?
Determining whether Baxter International Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Baxter International share price performance charts on this page. Our technical summary section provides analysis on Baxter share price buy/sell indicators using real-time data (or discuss the Baxter (BAX) stock price today with other investors in the Baxter NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE BAX share price (ISIN: US0718131099) to enhance your trading decisions with our free investment tools and resources.
What Is the Baxter International Share Price Today?
The Baxter share price today is 19.76.
What Is the Stock Symbol for Baxter International
The stock symbol (or 'ticker') for Baxter International Inc is "BAX."
What Stock Exchange Does Baxter International Trade On?
Baxter International Inc is listed and trades on the NYSE stock exchange.
Is Baxter International a Good Stock to Buy?
Determining whether Baxter International Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.61
20.13
52 wk Range
17.40
37.74
BAX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.6120.13
52 wk Range
17.4037.74
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.21%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.21%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BAX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
22.50
Upside
+13.75%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- Baxter Intl receives Investment Bank Analyst Rating Update
- Investing.com
Pro - CSCO, PLTR among market cap stock movers on Thursday
- Investing.com
- Baxter Intl receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Baxter Intl receives Investment Bank Analyst Rating Update
- Investing.com
Pro - CSCO, PLTR among market cap stock movers on Thursday
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Baxter Company Profile
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Baxter International Inc SWOT Analysis
Healthcare Titan | Baxter International, a $17.85B market cap leader in medical supplies, boasts a 55-year dividend streak amid industry shifts |
Analyst Optimism | Barclays reinstates Overweight rating with $39 price target, signaling renewed confidence in Baxter's market outperformance potential |
Financial Resilience | EPS projections show growth from $2.50 in FY2025 to $2.28 in FY2, with analysts predicting a return to profitability despite recent challenges |
Strategic Positioning | Baxter navigates regulatory hurdles and competitive pressures while capitalizing on aging populations and emerging markets for sustained growth |
Baxter International Inc Earnings Call Summary for Q4/2025
- Baxter's Q4 2025 EPS of $0.44 missed forecasts by 18.52%, despite revenue growth of 8% to $3 billion, causing stock to drop 12.8% pre-market
- Adjusted gross margin declined 900 basis points to 35.5%, while operating margin fell 340 basis points to 11.8% year-over-year, reflecting significant margin pressures
- CEO Andrew Hider acknowledged challenges but emphasized focus on innovation and operational improvements, with several product launches planned
- Company forecasts flat to 1% total sales growth for 2026, warning of a particularly challenging first quarter before anticipated improvements later in the year
- Despite current unprofitability (diluted EPS of -$0.67 over last 12 months), analysts predict profitability in fiscal 2025 with EPS forecast of $2.35
Last Updated: 12/02/2026, 15:02
Read Full TranscriptCompare BAX to Peers and Sector
Metrics to compare | BAX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBAXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.4x | 25.6x | −0.5x | |
PEG Ratio | - | 0.06 | 0.00 | |
Price/Book | 1.4x | 1.5x | 2.6x | |
Price / LTM Sales | 0.9x | 1.6x | 3.3x | |
Upside (Analyst Target) | 12.2% | 0.0% | 46.6% | |
Fair Value Upside | Unlock | 46.3% | 6.4% | Unlock |
Analyst Ratings
3 Buy
13 Hold
1 Sell
Ratings:
17 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 22.50
(+13.75% Upside)
Earnings
Latest Release
Feb 12, 2026
EPS / Forecast
0.44 / 0.54
Revenue / Forecast
2.97B / 2.84B
People Also Watch
FAQ
What Is the Baxter (BAX) Share Price Today?
The live Baxter share price today is 19.78
What Stock Exchange Does Baxter (BAX) Trade On?
Baxter is listed and trades on the New York Stock Exchange.
What Is the Ticker (Stock Symbol) for Baxter?
The stock symbol (also called a 'ticker') for Baxter is "BAX."
Does Baxter Pay Dividends? What’s The Current BAX Dividend Yield?
Yes, BAX Pays Dividends to its Shareholders. The current Baxter dividend yield is 0.21%.
What Is the Current Baxter Market Cap?
As of today, Baxter market capitalisation is 10.19B.
What Is Baxter's (BAX) Earnings Per Share (TTM)?
The Baxter EPS is currently -1.87 (Trailing Twelve Months).
When Is the Next Baxter Earnings Date?
Baxter's next earnings report will be released on 30/04/2026.
Is BAX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Baxter moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Baxter Stock Split?
Baxter has split 4 times. (See the BAX stock split history page for full effective split date and price information.)
How Many Employees Does Baxter Have?
Baxter has 38000 employees.
What is the current trading status of Baxter (BAX)?
As of 13 Feb 2026, Baxter (BAX) is trading at a price of 19.78, with a previous close of 18.71. The stock has fluctuated within a day range of 18.61 to 20.13, while its 52-week range spans from 17.40 to 37.74.
What Is Baxter (BAX) Price Target According to Analysts?
The average 12-month price target for Baxter is USD22.50, with a high estimate of USD40 and a low estimate of USD15. 3 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +13.75% Upside potential.
What Is the BAX Premarket Price?
BAX's last pre-market stock price is 18.86. The pre-market share volume is 11,540.00, and the stock has decreased by 0.15, or 0.83%.
What Is the BAX After Hours Price?
BAX's last after hours stock price is 19.79, the stock has decreased by 0.01, or 0.05%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.